Elisabetta Moscarella

Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial

Francesco Costa, P Vranckx, Sergio Leonardi et al. · European Heart Journal · 2015 · 85 citations

Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk

Arturo Cesaro, Felice Gragnano, Fabio Fimiani et al. · European Journal of Preventive Cardiology · 2019 · 78 citations

Hypertension, Heart Failure, Cardiovascular Disease +9

Incremental Value of the CRUSADE, ACUITY, and HAS‐BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy

Francesco Costa, Jan G.P. Tijssen, Sara Ariotti et al. · Journal of the American Heart Association · 2015 · 76 citations · Full text

IntravaScular Lithotripsy for the Management of UndILatable Coronary StEnt: The SMILE Registry

Alfonso Ielasi, Elisabetta Moscarella, Luca Testa et al. · Cardiovascular revascularization medicine · 2020 · 52 citations

Percutaneous Coronary Intervention, Endovascular Technique, Cardiovascular Disease +11

Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre “Registro ABSORB Italiano” (RAI registry)

Alfonso Ielasi, Bernardo Cortese, Attilio Varricchio et al. · EuroIntervention · 2015 · 48 citations